3,5,6,7,8,31,41 -Heptamethoxyflavone, a citrus flavonoid, Ameliorates corticosterone-induced depression-like behavior and restores brain-derived neurotrophic factor expression, neurogenesis, and neuroplasticity in the hippocampus

Molecules

Volumn 21, Issue 4, 2016, Pages

  Sawamoto, Atsushi ^a   Okuyama, Satoshi ^a   Yamamoto, Kana ^a   Amakura, Yoshiaki ^a   Yoshimura, Morio ^a   Nakajima, Mitsunari ^a   Furukawa, Yoshiko ^a  

^a MATSUYAMA UNIVERSITY   (Japan)

Author keywords

Brain derived; Corticosterone; Depression; Heptamethoxyflavone; Hippocampus; Neurogenesis; Neurotrophic factor

Indexed keywords

3,3',4',5,6,7,8-HEPTAMETHOXYFLAVONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; FLAVONOID;

ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; CITRUS; CYTOLOGY; DEPRESSION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; METABOLISM; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITRUS; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; FLAVONOIDS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; NEUROGENESIS; NEURONAL PLASTICITY;

EID: 84966262774     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21040541     Document Type: Article

References (41)

1. Charney, D.S.; Manji, H.K. Life stress, genes, and depression: Multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE 2004, 225, re5. [CrossRef] [PubMed]
2. Pariante, C.M.; Lightman, S.L. The HPA axis in major depression: Classical theories and new developments. Trends Neurosci. 2008, 31, 464-468. [CrossRef] [PubMed]
3. Dinan, T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br. J. Psychiatry 1994, 164, 365-371. [CrossRef] [PubMed]
4. Duman, R.; Monteggia, I. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59, 1116-1127. [CrossRef] [PubMed]
5. Ye, Y.; Wang, G.; Wang, H.; Wang, X. Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression. Neurosci. Lett. 2011, 503, 15-19. [CrossRef] [PubMed]
6. Paizanis, E.; Hamon, M.; Lanfumey, L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast. 2007, 2007. [CrossRef] [PubMed]
7. Martinowich, K.; Manji, H.; Lu, B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007, 10, 1089-1093. [CrossRef] [PubMed]
8. Okuyama,S. Morita M. Miyoshi, K. Nishigawa, Y. Kaji M. Sawamoto A. Terugo T. Toyoda N. Makihata N. Amakura Y.et al.3,5,6,7,8,31 ,41 -Heptamethoxyflavone, a citrus flavonoid, on protection against memory impairment and neuronal cell death in a global cerebral ischemia mouse modelNeurochem. Int.20147030-38[CrossRef] [PubMed]
9. Okuyama, S.; Shimada, N.; Kaji, M.; Morita, M.; Miyoshi, K.; Minami, S.; Amakura, Y.; Yoshimura, M.; Yoshida, T.; Watanabe, S.; et al. Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in mice. Neurosci. Lett. 2012, 528, 190-195. [CrossRef] [PubMed]
10. Antonijevic, I.A.; Steiger, A. Depression-like change of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology 2003, 28, 780-795. [CrossRef]
11. Shibata, S.; Iinuma, M.; Soumiya, H.; Fukumitsu, H.; Furukawa, Y.; Furukawa, S. A novel 2-decenoic acid thioester ameliorates corticosterone-induced depression- and anxiety-like behaviors and normalizes reduced hippocampal signal transduction in treated mice. Pharmacol. Res. Perspect. 2015, 3, e00132. [CrossRef] [PubMed]
12. Jacobsen, J.P.; Mørk, A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 2006, 1110, 221-225. [CrossRef] [PubMed]
13. Dwivedi, Y.; Rizavi, H.S.; Pandey, G.N. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: Differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 2006, 139, 1017-1029. [CrossRef] [PubMed]
14. Mostert, J.P.; Koch, M.W.; Heerings, M.; Heersema, D.J.; de Keyser, J. Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci. Ther. 2008, 14, 153-164. [CrossRef] [PubMed]
15. Shen, J.D.; Ma, L.G.; Hu, C.Y.; Pei, Y.Y.; Jin, S.L.; Fang, X.Y.; Li, Y.C. Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice. Neurosci. Lett. 2016, 614, 77-82. [CrossRef] [PubMed]
16. Zhao, Y.; Ma, R.; Shen, J.; Su, H.; Xing, D.; Du, L. A mouse model of depression induced by repeated corticosterone injections. Eur. J. Pharmacol. 2008, 581, 113-120. [CrossRef] [PubMed]
17. Cryan, J.F.; Valentino, R.J.; Lucki, I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29, 547-569. [CrossRef] [PubMed]
18. Kimpton, J. The brain derived neurotrophic factor and influences of stress in depression. Psychiatr. Danub. 2012, 24, 169-171.
19. Mayer, J.L.; Klumpers, L.; Maslam, S.; de Kloet, E.R.; Joëls, M.; Lucassen, P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J. Neuroendocrinol. 2006, 18, 629-631. [CrossRef] [PubMed]
20. Oomen, C.A.; Mayer, J.L.; de Kloet, E.R.; Joëls, M.; Lucassen, P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur. J. Neurosci. 2007, 26, 3395-3401. [CrossRef] [PubMed]
21. Luěí V.; Greif, G.J.; Kennedy, M.B. Detailed State Model of CaMKII Activation and Autophosphorylation. Eur. Biophys. J. 2008, 38, 83-98. [CrossRef] [PubMed]
22. Gourley, S.L.; Wu, F.J.; Taylor, J.R. Corticosterone regulates pERK1/2 map kinase in a choronic depression model. Ann. N. Y. Acad. Sci. 2008, 1148, 509-514. [CrossRef] [PubMed]
23. Gourley, S.L.; Wu, F.J.; Kiraly, D.D.; Ploski, J.E.; Kedves, A.T.; Duman, R.S.; Taylor, J.R. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 2008, 63, 353-359. [CrossRef] [PubMed]
24. Furukawa, Y.; Okuyama, S.; Amakura, Y.; Watanabe, S.; Fukata, T.; Nakajima, M.; Yoshimura, M.; Yoshida, T. Isolation and characterization of activators of ERK/MAPK from citrus plants. Int. J. Mol. Sci. 2012, 13, 1832-1845. [CrossRef] [PubMed]
25. Cryan, J.F.; Mombereau, C. In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Mol. Psychiatry 2004, 9, 326-357. [CrossRef] [PubMed]
26. Castrén, E. Is mood chemistry? Nat. Rev. Neurosci. 2005, 6, 241-246. [CrossRef] [PubMed]
27. Maya Vetencourt, J.F.; Sale, A.; Viegi, A.; Baroncelli, L.; De Pasquale, R.; O'Leary, O.F.; Castrén, E.; Maffei, L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320, 385-388. [CrossRef] [PubMed]
28. Haase, J.; Brown, E. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression-a central role for the serotonin transporter? Pharmacol. Ther. 2015, 147. [CrossRef] [PubMed]
29. Nemeth, C.L.; Miller, A.H.; Tansey, M.G.; Neigh, G.N. Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors. Behav. Brain Res. 2016, 303, 160-167. [CrossRef] [PubMed]
30. Pittenger, C.; Duman, R.S. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 2008, 33, 88-109. [CrossRef] [PubMed]
31. Sairanen, M.; Lucas, G.; Ernfors, P.; Castrén, M.; Castrén, E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25, 1089-1094. [CrossRef] [PubMed]
32. Djordjevic, A.; Djordjevic, J.; Elakoviæ, I.; Adzic, M.; Matiæ, G.; Radojcic, M.B. Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex. Eur. J. Pharmacol. 2012, 693, 37-44. [CrossRef] [PubMed]
33. Freitas, A.E.; Machado, D.G.; Budni, J.; Neis, V.B.; Balen, G.O.; Lopes, M.W.; de Souza, L.F.; Dafre, A.L.; Leal, R.B.; Rodrigues, A.L. Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice. Behav. Brain Res. 2013, 237, 176-184. [CrossRef] [PubMed]
34. Czéh, B; di Benedetto, B. Antidepressants act directly on astrocytes: Evidences and functional consequences. Eur. Neuropsychopharmacol. 2013, 23, 171-185.
35. Cobb, J.A.; Simpson, J.; Mahajan, G.J.; Overholser, J.C.; Jurjus, G.J.; Dieter, L.; Herbst, N.; May, W.; Rajkowska, G.; Stockmeier, C.A. Hippocampal volume and total cell numbers in major depressive disorder. J. Psychiatr. Res. 2013, 47, 299-306. [CrossRef] [PubMed]
36. Sheline, Y.I.; Gado, M.H.; Kraemer, H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160, 1516-1518. [CrossRef] [PubMed]
37. Zhang, H.; Zhao, Y.; Wang, Z. Chronic corticosterone exposure reduces hippocampal astrocyte structural plasticity and induces hippocampal atrophy in mice. Neurosci. Lett. 2015, 592, 76-81. [CrossRef] [PubMed]
38. Rial, D.; Lemos, C.; Pinheiro, H.; Duarte, J.M.; Gonçalves, F.Q.; Real, J.I.; Prediger, R.D.; Gonçalves, N.; Gomes, C.A.; Canas, P.M.; et al. Depression as a Glial-Based Synaptic Dysfunction. Front. Cell. Neurosci. 2016, 9. [CrossRef] [PubMed]
39. Porsolt, R.D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. 1997, 229, 327-336.
40. Steru, L.; Chermat, R.; Thierry, B.; Simon, P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 1985, 85, 367-370. [CrossRef] [PubMed]
41. Sato, S.; Xu, J.; Okuyama, S.; Martinez, L.B.; Walsh, S.M.; Jacobsen, M.T.; Swan, R.J.; Schlautman, J.D.; Ciborowski, P.; Ikezu, T. Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J. Neurosci. 2008, 28, 14511-14521. [CrossRef] [PubMed]